FDA Investigator Abby E Pelletier

Abby E Pelletier has inspections in 3 countries as of 09 Nov 2023. Abby E Pelletier has collaborated with a combinined 3448 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
177
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100002902
Country:
United States of America, Canada, India
Co-Investigator(s):
A Williams, Aaron L Morris, Alan R Condon, Alfred P Pistorio, Alice C Silva, Allison A Rodriguez, Almaris N Alonso, Alois P Provost, Alysia M Salonia, Alyssa R Favro, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Angela J Davis, Ann L Demarco, Anthony J Ladner, Anthony N Onianwa, Anthony W Thomas, Arsen Karapetyan, Ashley M Whitehurst, Azza Talaat, Bradford L Swanson, Brandy L Couillard, Brandy L Gillilan, Brenda P King, Brian R Sweeney, Brian R Yaun, Camerson E Moore, Carl A Huffman, III, Carla C Tuite, Christopher A Demitrius, Christopher K Vantwuyver, Christopher M Elliott, Clinton V Giustra, Concepcion Cruz, Jr, Constance Desimone, Daniel J Roberts, Darin S Wiegers, David A Oluwo, David C Sullivan, David J Feria, David P Vanhouten, Dawn M Braswell, Dean R Rugnetta, Debra I Love, Dianiris C Ayala, Dominic R Frasca, Dorothy W Lee, Douglas Florentino, Douglas S Joslin, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Eileen A Liu, Eileen T Maher, Elise L Mcdevitt, Elizabeth B Griffin, Ellen P Madigan, Emily J Schramm, Emir Galevi, Eric C Schmitt, Erica B Raphael, Erik W Koester, Garry H Stewart, Gary J Hagan, George T Allen, Jr, Gerard D Difiore, Guozhou Mo, Harperd, Irons, Jacqueline Mdiaz Albertini, James P Finn, James W Whitney, Jamie S Mathews, Jason A Rossi, Jeffrey J Thibodeau, John A Hamilton, III, John A Sciacchitano, John L Zaccone, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonathan B Lewis, Jonathan G Matrisciano, Joseph B Cascio, Joseph H Procopio, Joseph T Frost, Joyce A Kellett, Juan Rjimenez Garcia, Justin A Boyd, Justine M Corson, Karen L Kosar, Katarzyna Plona, Kathleen E Mcafoose, Kenneth H Williams, Kent A Conforti, Kevin P Foley, Laiza V Garcia, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Lisa M Ayer, Logan T Williams, Louis Christy, LT Luis O Rodriguez, Lucila B Nwatu, Lyndsay M Perryman, Lynne M Dwyer, M Patriciaurphy Murphy, Marcia M Laughrey, Margaret E Walsh, Margaret M Sands, Mark E Farrell, Mark K Tseng, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew B Casale, Matthew C Watson, Matthew D Silverman, Matthew W Kyle, Maura Rooney, Maureen L Dreher, Megan A Haggerty, Michael G Mayfield, Michael J Leal, Michael J Pasternak, Michael L Casner, Michael P Sweeney, Michelle M Noe, Mutahar S Shamsi, Nabil Nakhoul, Nadia R Barreda, Narong Chamkasem, PhD, Nassim Ben Makhlouf, Nathan B Davis, Neil J Bonzagni, PhD MPH, Nichole B Murphy, Nydia E Colon, Pamela L Ogonowski, Paraluman S Leonin, Paul E Stein, Paul P Geraci, Paula M Laplant, Philip H Lafleur, Preston M Lee, Qiao Y Bobo, Rafeeq A Habeeb, Rebecca A Coleman, Richard F Hapke, Richard K Vogel, Richard L Licari, Rita K Kabaso, Robert J Martin, Robert Mo Brien, Ronald T Weber, Rory K Geyer, Rupa Pradhan, Sandra P White, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sara M Onyango, Sara M Richardson, Scott M Loughan, Sean M Tessicini, Sean R Marcsisin, Seth A Mailhot, Shawn M Bogdan, Sherry K Markwell, Slater K Bartlett, Stacey S Degarmo, State Agency, Stephen C King, Stephen C Smith, Stephen D Brown, Stephen R Souza, Steven P Donald, Sunita Pandey, Susanne M Richardson, MSc RAC ELS, Suzanne M Healy, Tamara S Rosbury, Tania K Mercado, Teddy Tom, Terry C Kimball, Thomas J Arista, Thomas O Morgan, Todd J Maushart, Tonia F Bernard, Torrance J Slayton, Troy R Petrillo, Unnee Ranjan, Vilmary Negron Rodriguez, Wanda J Torres, Yasamin Ameri

Abby E Pelletier's Documents

Publish Date Document Type Title
June, 2011 FDA 483 Morgan Scientific, Inc. - Form 483, 2011-06-10
January, 2017 EIR Mobius Bionics, LLC - EIR, 2017-01-26
May, 2010 FDA 483 Hightech American Industrial Laboratories, Inc. - Form 483, 2010-05-27
December, 2015 FDA 483 Dartmouth Hitchcock Medical Center - Form 483, 2015-12-29
December, 2016 FDA 483 TESco Associates, Inc. - Form 483, 2016-12-13
September, 2013 FDA 483 White Mountain Imaging - Form 483, 2013-09-19
November, 2016 EIR AgaMatrix Inc - EIR, 2016-11-21
July, 2011 FDA 483 Vygon MFG, Inc., dba/ Churchill Medical Systems, Inc. - Form 483, 2011-07-28
April, 2017 FDA 483 TransMedics, Inc. - Form 483, 2017-04-26
July, 2016 FDA 483 SleepNet Corporation - Form 483, 2016-07-18
June, 2018 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2018-06-08
January, 2010 FDA 483 Guidewire Technologies, Inc. - Form 483, 2010-01-22
August, 2017 FDA 483 Arch Medical Solutions - Seabrook - Form 483, 2017-08-07
June, 2012 FDA 483 The Prometheus Group - Form 483, 2012-06-21
April, 2016 FDA 483 Kat Implants, LLC - Form 483, 2016-04-07
June, 2010 FDA 483 Cardea Technology, Inc - Form 483, 2010-06-21
December, 2017 FDA 483 J-PAC, LLC - Form 483, 2017-12-15
January, 2017 FDA 483 Corflex, Inc. - Form 483, 2017-01-04
February, 2016 FDA 483 NextPhase Medical Devices LLC - Form 483, 2016-02-04
August, 2016 FDA 483 Renegade Wheelchairs, LLC - Form 483, 2016-08-26
July, 2012 FDA 483 Holistic Technologies, LLC - Form 483, 2012-07-10
February, 2017 FDA 483 Eptam Plastics, LLC - Form 483, 2017-02-07
May, 2018 FDA 483 Vygon MFG, Inc., dba/ Churchill Medical Systems, Inc. - Form 483, 2018-05-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more